SCHEMBL13348773

SCHEMBL13348773

CC(=O)c1ccc(-c2ccccc2S)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
MAOB P27338 1/20 0.49
S100A4 P26447 1/20 0.49
HSD17B1 P14061 2/20 0.48
HPGD P15428 4/20 0.44
LMNA P02545 4/20 0.44
ALDH1A1 P00352 1/20 0.44
PTPN6 P29350 1/20 0.44
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
PTGS1 P23219 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.41
SGK1 O00141 1/20 0.40
KIF11 P52732 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11448863 0.86 MAPT (0.71) MAPTSMN1; SMN2MAOBS100A4HSD17B1
SCHEMBL12332689 0.84 MAPT (0.68) MAPTSMN1; SMN2MAOBS100A4HSD17B1
SCHEMBL12101146 0.82 TSHR (0.50) MAPTRAB9ANPC1
SCHEMBL10296041 0.82 MAPT (0.79) MAPTSMN1; SMN2MAOBS100A4HSD17B1
SCHEMBL3282326 0.81 MEN1 (0.55) MAPTSMN1; SMN2HPGDLMNAALDH1A1
SCHEMBL10178616 0.81 NPSR1 (0.38) MAPTSMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL13232064 0.80 MAPT (0.63) MAPTSMN1; SMN2MAOBS100A4HSD17B1
Hydrogen Sulfide SCHEMBL28788713 0.80 MAPT (0.76) MAPTSMN1; SMN2MAOBS100A4HSD17B1
SCHEMBL2772796 0.78 MAPT (0.61) MAPTSMN1; SMN2MAOBS100A4HSD17B1
SCHEMBL10955727 0.78 SMN1; SMN2 (0.61) MAPTSMN1; SMN2MAOBS100A4HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727982-B2 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
US-7727981-B2 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
US-7314874-B2 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo MILLENNIUM PHARMACEUTICALS, INC. (US) 2008-01-01 US disclosed